Treatment of Epilepsy

Michael Rogawski (University of California, Davis) summarizes his research on the antiepileptic activity of... » More

Michael Rogawski (University of California, Davis) summarizes his research on the antiepileptic activity of neurosteroids (e.g. ganaxolone, allopregnanolone). They are allosteric modulators of GABAA receptors and are active in many models of epilepsy. They are expected, however, to be most
effective in catamenial epilepsy, infantile spasms or adult partial seizures. National Institutes of Health (NIH) is currently sponsoring a clinical trial of progesterone (precursor of allopregnanolone) in catamenial (menstrual) epilepsy; Marinus Pharmaceuticals is evaluating ganaxolone in the same
condition. « Hide